# Biomat USA, Inc. – FDA Inspection, Sep 28, 2011

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/093aa39b-ce78-4378-b69a-e35d85e92b01
Source feed: FDA_Inspections

> FDA inspection 747161 of Biomat USA, Inc., September 28, 2011. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 747161
- Company Name: Biomat USA, Inc.
- Inspection Date: 2011-09-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1201080 - 2023-03-24
- [FDA Inspection 1039319 - 2018-02-01](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c0373e11-1ba4-4db2-9682-283a58cb0d52)
- [FDA Inspection 835567 - 2013-06-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/949fc6e4-460b-47e4-89c5-5c35d75eda2b)

Company: https://www.keypedia.com/companies/biomat-usa-inc/07396b1c-e99b-4699-bce4-4e111e2b04ef

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d